Florence Poirier

Title: Florence Poirier: Innovator in Colorectal Cancer Diagnostics

Introduction

Florence Poirier is a notable inventor based in Saint-Denis, France. She has made significant contributions to the field of medical diagnostics, particularly in the area of colorectal cancer. With a total of two patents to her name, her work focuses on innovative methods for early diagnosis and monitoring of this critical health issue.

Latest Patents

Florence Poirier's latest patents include a method of assaying Apolipoprotein AI for the in vitro diagnosis of colorectal cancer. This method involves assessing the levels of Apolipoprotein AI, Apolipoprotein AII, E-Cadherin, and Galectin-3 in a biological sample from individuals suspected of having colorectal cancer, with the sample being remote from any tumor. Another significant patent is the Apolipoprotein AII assay method for the in vitro diagnosis of colorectal cancer. This invention relates to determining the presence of the Apolipoprotein AII tumor marker in a biological sample taken from a patient suspected of having colorectal cancer. This method is valuable for early diagnosis, screening, therapeutic follow-up, prognosis, and relapse diagnosis related to colorectal cancer.

Career Highlights

Throughout her career, Florence Poirier has worked with prominent companies in the medical field, including bioMérieux, Inc. and bioMérieux. Her experience in these organizations has allowed her to develop and refine her innovative diagnostic methods.

Collaborations

Florence has collaborated with esteemed colleagues such as Yasemin Ataman-Onal and Jean-Philippe Charrier. These partnerships have contributed to her success and the advancement of her research in colorectal cancer diagnostics.

Conclusion

Florence Poirier is a pioneering inventor whose work in colorectal cancer diagnostics has the potential to improve early detection and treatment outcomes. Her innovative methods and collaborations highlight her commitment to advancing medical science.